Recently, the Hepatitis C Treatment Information Project has received a number of inquiries, all wanting to know more about support programs available through the pharmaceutical companies.
Therefore, below is a list of the assistance programs created by the pharmaceutical companies to help people interested in or already taking their hep C treatments.
Pharmaceutical Company Assistance Programs
Canadians prescribed Holkira Pak (ombitasvir/paritaprevir/ritonavir and dasabuvir) can request to be enrolled in AbbVie Care. The program is designed to provide a wide range of customized services including reimbursement assistance, education, and ongoing disease management support. AbbVie Care will not only support people living with genotype 1 hepatitis C throughout their treatment but healthcare professionals as well. For more information, contact your doctor, nurse, or call the program at: 1-844-471-2273.
Gilead’s Momentum Patient Assistance Program
Canadians prescribed Harvoni (ledipasvir and sofosbuvir) or Sovaldi (sofosbuvir) have the opportunity to request to be enrolled in the Gilead Momentum Program. For more information, contact your doctor, nurse, or call the program at: 1-855-447-7977.
Ibavyr Patient Support Program
Canadians prescribed ribavirin (Ibavyr) as part of their hep C treatment have the opportunity to request to be enrolled in the Ibavyr Patient Support Program. For more information, contact your doctor, nurse, or call the program at: 1-844-602-6858.
Janssen’s Galexos: Bioadvance Program
Janssen Inc. has created the Galexos: Bioadvance Program, which is a patient support program designed to provide patient health information and reimbursement assistance for patients who have been prescribed Galexos (simeprevir). This specialized patient support program represents a service offered at no cost to the patient and is fully confidential. For more information , contact your doctor, nurse, or call the program at: 1-855-512-3740.
Merck Care Program
For people who are being prescribed Victrelis, pegylated interferon and ribavirin (Pegasys), or Victrelis with pegylated interferon and ribavirin (Victrelis Triple), Merck has Merck Care Program. For more information, contact your doctor, nurse, or call the program at: 1-866-872-5773.
PEGAssist Patient Support Program
Hoffmann-La Roche Inc. offers this patient assistance program for people who have been prescribed pegylated interferon (Pegasys) as part of their hepatitis C treatment. For more information, contact your doctor, nurse, or call the program at: 1-877-734-2797.
Information About Other Assistance Programs
Information about other assistance programs can be found on the Hep C Treatment Information Project’s Financial Support page. Our Considering Treatment page also includes information for those wondering about starting treatment or looking for support groups.
For more information about hep C support programs, currently approved hep C treatments, or emerging treatments, please visit PHCN’s Hepatitis C Treatment Information Project or email firstname.lastname@example.org.